Purpose/Objective: Pre-treatment quality assurance of radiotherapy plans is an essential check of the treatment planning system (TPS) dose calculation, as well as the plan transfer to the linear accelerator. With increasing numbers of complex treatmentsincluding volumetric modulated arc therapy (VMAT) -the burden of individual linac-based QA has implications for workflow. In this work we introduce an automated Monte Carlo verification system for VMAT treatments, with the aim of reducing or replacing linac measurements. The system allows dose statistics to be reported for individual ROIs, and is able to accept plans exported from a recordand-verify system, allowing a two-way check of plan transfer.
Materials and Methods:
The verification system is triggered when DICOM-RT format files (plan, CT, structures and dose) are exported from a TPS. The system automatically prepares and reformats the files into instructions for Monte Carlo simulation using GATE/GEANT4. Calculations on the patient's CT dataset are then scheduled on a 44 CPU cluster. The outputs are automatically merged and gamma analysis performed against the planned dose distribution. In order to validate the Monte Carlo model, comparisons were made to water tank measurements for depth-dose curves, profiles and output factors. Further validation was performed by delivering 5 prostate and 5 head and neck VMAT plans to a cylindrical phantom (Delta4), and comparing the results to Monte Carlo simulations of the same geometry. To demonstrate the potential of the system for routine use, a prostate and head and neck VMAT patient were verified and their results interpreted.
Results:
The model showed good agreement against water tank measurements, with >95% of points passing a 2%/2mm gamma analysis for depth-dose curves at a range of field sizes. Validation of the VMAT simulation against the Delta4 gave results consistent with our accepted tolerance for pre-treatment QA, with pass rates of 98.6 (± 0.9) % for the prostates and 95.8 (± 2.6) % for the head and necks at the 3%/3mm gamma level. Full dosimetric verification on a patients CT data took the system 10-12 hours on the present computing cluster, in order to achieve < 2% uncertainty within the 5 % isodose volume. By setting up verification 'templates' for individual sites, it was possible to report the gamma passes for various relevant ROIs within prostate and head and neck plans.
Conclusions: An automated Monte Carlo verification system has been developed which allows for accurate, independent dose calculations on the patient CT dataset. ROI-specific results can be reported. Export is also allowed from a record-and-verify system to check plan transfer. This system demonstrates that highly complex plan QA can be performed using a software solution, allowing for the possibility of reducing or replacing machine-based measurements. Work is now being done to determine tolerances for the calculations, and expansion of the cluster is underway to meet clinical demands. 
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Materials and Methods:
The treatment planning system automatically generates a steering file per field of each plan containing the information about selected Bragg peaks, their position and weights. Dosimetric verification of every steering file then consists of a measurement of two orthogonal profiles using an ionization chamber array consisting of two arms of thirteen ionization chambers each at a single depth in water. This is mounted on an automatically controlled water column such that measurements at different depths can be performed as required. The measured profiles are directly sent to the treatment planning system where they are compared with the predicted doses. Results: A summary of the results is shown in figure 1 . The analysis of all verified IMPT fields have shown that more than 96% of verified fields were within our defined tolerances. There were no systematic errors in the position of the beam in relation to the isocenter or for the range in water. In addition, the precision (SD), calculated over all fields, is within ± 0.8 mm (SD) in all three directions. In the absolute dose, we have an accuracy of about 0.6 % of the predicted dose and precision of ±1.30 %. Although a small number of verifications were out of tolerance, most of these were due to problems with the measurement itself, e.g. chamber / water column calibration problems, malfunctioning ionisation chambers or bad cable connections.
